Information  X 
Enter a valid email address

4D Pharma PLC Ord 0.25P (DDDD)

Date Time Source Announcement
19 Nov 2021 5:58 pm
RNS
Holding(s) in Company
11 Nov 2021 7:00 am
RNS
4D pharma Jefferies Healthcare Conference
12 Oct 2021 7:00 am
RNS
Jefferies Next Generation IBD Therapeutics Summit
30 Sep 2021 7:00 am
RNS
Half-year Report
16 Sep 2021 2:08 pm
RNS
Holding(s) in Company
15 Sep 2021 7:00 am
RNS
4D pharma presents two posters at ESMO Congress
09 Sep 2021 7:00 am
RNS
Participation in Upcoming Investor Conferences
19 Aug 2021 9:44 am
RNS
Holding(s) in Company
02 Aug 2021 7:00 am
RNS
Two MRx0518 presentations accepted for ESMO 2021
29 Jul 2021 7:00 am
RNS
$30 Million Credit Facility with Oxford Finance
26 Jul 2021 1:00 pm
RNS
Passing of Chief Financial Officer John Beck
06 Jul 2021 7:00 am
RNS
Publication - LBP improves activity of CAR-T
29 Jun 2021 7:00 am
RNS
Ladenburg Thalmann Healthcare Conference
22 Jun 2021 7:00 am
RNS
Conference presentation on LBP Manufacturing'
04 Jun 2021 7:00 am
RNS
Asthma trial Part A enrolment and program update
01 Jun 2021 8:52 am
RNS
Total Voting Rights
24 May 2021 10:48 am
RNS
Result of AGM
  7:00 am
RNS
Update on Data for Phase II Study of Blautix
17 May 2021 7:00 am
RNS
Presentation of Blautix IBS Phase II at DDW 2021
19 Apr 2021 7:00 am
RNS
Collaboration with Parkinson's UK
16 Apr 2021 7:00 am
RNS
Directors' Subscription for new Ordinary Shares
15 Apr 2021 5:00 pm
RNS
Annual Financial Report
  7:00 am
RNS
Participation in Jefferies Therapeutics Summit
12 Apr 2021 2:26 pm
RNS
Holding(s) in Company
07 Apr 2021 7:00 am
RNS
How to Convert AIM Ordinary Shares into Nasdaq ADS
01 Apr 2021 7:00 am
RNS
Final Results
26 Mar 2021 3:21 pm
RNS
Holding(s) in Company
25 Mar 2021 12:08 pm
RNS
Holding(s) in Company
  8:00 am
RNS
Holding(s) in Company
22 Mar 2021 7:00 am
RNS
Completion of Merger
18 Mar 2021 1:25 pm
RNS
Result of Meeting
17 Mar 2021 1:00 pm
RNS
4D Pharma Announces Private Placement
03 Mar 2021 7:00 am
RNS
Investor conference participation
01 Mar 2021 5:49 pm
RNS
Exercise of Options and Total Voting Rights
  7:02 am
RNS
John Beck Appointed as Chief Financial Officer
  7:00 am
RNS
Appoints Paul Maier to the Board as NED
26 Feb 2021 12:52 pm
RNS
Holding(s) in Company
  7:02 am
RNS
Posting of Circular
  7:00 am
RNS
U.S. SEC Declares Registration Statement Effective
16 Feb 2021 7:00 am
RNS
Microbiome Leaders Panel Event
08 Feb 2021 7:45 am
RNS
Holding(s) in Company
  7:00 am
RNS
Oncology Clinical Collaboration
04 Feb 2021 2:55 pm
RNS
Holding(s) in Company
03 Feb 2021 7:00 am
RNS
Oncology Program Update
01 Feb 2021 2:10 pm
RNS
Total Voting Rights
27 Jan 2021 7:00 am
RNS
Holding(s) in Company
25 Jan 2021 6:01 pm
RNS
Holding(s) in Company
21 Jan 2021 7:00 am
RNS
Conference participation
30 Dec 2020 8:32 am
RNS
Holding(s) in Company
29 Dec 2020 5:17 pm
RNS
Holding(s) in Company
  2:24 pm
RNS
Holding(s) in Company
22 Dec 2020 2:31 pm
RNS
Holding(s) in Company
18 Dec 2020 8:53 am
RNS
Joins MJFF-sponsored Parkinson's study consortium
27 Nov 2020 3:42 pm
RNS
Holding(s) in Company
26 Nov 2020 7:09 am
RNS
Registration Statement filed with SEC
23 Nov 2020 7:00 am
RNS
Longevity extends Business Combination deadline
12 Nov 2020 12:18 pm
RNS
Holding(s) in Company
09 Nov 2020 6:21 pm
RNS
Holding(s) in Company
  1:00 pm
RNS
SITC data MRx0518 monotherapy and combination
05 Nov 2020 12:00 pm
RNS
Virtual KOL Event SITC Data

a d v e r t i s e m e n t